English

    Overview

  • Dr. Rajendra Pol is a distinguished haematologist in Baner, Pune, who did an MBBS from Pune University in the year 1999, he pursued an MD in medicine from Pune University in the year 2002. Dr. Rajendra then relocated to the UK and further pursued MRCP Medicine in the year 2006 from the Royal College of Physicians U.K. He then achieved FRCPathology-Hematology from the Royal College of Physicians UK in the year 2014 a fellowship in Bone marrow Transplant in the years 2015-2016 satisfying the BSBMT UK curriculum. Dr. Pol over 20 years has done over 5000 autologous transplants, 1000 allogeneic transplants (donors from siblings, unrelated matched, umbilical cord, and haploidentical sources), and 55 CAR-T therapies. Dr. Rajendra has more than 12 years of experience in the field and is one of the highly trusted haematologists in Pune.

  • He also achieved expertise in CAR-T therapy in Manchester for a year. He is an expert in interpreting Bone marrow Biopsies and correlating with MRD and molecular studies pre and post-allogeneic stem cell transplantation. His expertise is in Bone marrow / Haematopoetic stem cell transplantation, He does chemotherapies and has been known to treat a variety of bone marrow cancers like Leukemia, Lymphoma, Myeloma, Bone marrow failures, etc. He has been a Principal Investigator for many UK and International trials like the MoTD trial for allogeneic stem cell transplant recipients, Sub-Investigator for allogeneic transplant, and CAR-T trials – Amadeus, COSI, MERC K, ALL-RIC, AUTO3, AUTO4, AUTO1, AUTO LT FU Sub-Investigator for Myeloid malignancies trials – AML18, AML19, PACE.

  • In addition to academic and professional excellence, Dr. Rajendra is proficient in Hindi, English, Marathi and Gujarati. He has treated patients from across the country and believes in having interactive communication with the patients. This helps him create a personalised treatment plan and enhances the patient experience. 

  • Field of Expertise

  • Haematology
  • Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.
  • Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati
  • Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.
  • World Thalassemia Day: Dr. Rajendra Pol, Haematologist at Manipal Hospital, Baner, Pune. Click Here
  • World Sickle Cell Day: All you need to know about Sickle cell - Dr Rajendra Pol. Click Here

    Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.
  • Overview

  • Dr. Rajendra Pol is a distinguished haematologist in Baner, Pune, who did an MBBS from Pune University in the year 1999, he pursued an MD in medicine from Pune University in the year 2002. Dr. Rajendra then relocated to the UK and further pursued MRCP Medicine in the year 2006 from the Royal College of Physicians U.K. He then achieved FRCPathology-Hematology from the Royal College of Physicians UK in the year 2014 a fellowship in Bone marrow Transplant in the years 2015-2016 satisfying the BSBMT UK curriculum. Dr. Pol over 20 years has done over 5000 autologous transplants, 1000 allogeneic transplants (donors from siblings, unrelated matched, umbilical cord, and haploidentical sources), and 55 CAR-T therapies. Dr. Rajendra has more than 12 years of experience in the field and is one of the highly trusted haematologists in Pune.

  • He also achieved expertise in CAR-T therapy in Manchester for a year. He is an expert in interpreting Bone marrow Biopsies and correlating with MRD and molecular studies pre and post-allogeneic stem cell transplantation. His expertise is in Bone marrow / Haematopoetic stem cell transplantation, He does chemotherapies and has been known to treat a variety of bone marrow cancers like Leukemia, Lymphoma, Myeloma, Bone marrow failures, etc. He has been a Principal Investigator for many UK and International trials like the MoTD trial for allogeneic stem cell transplant recipients, Sub-Investigator for allogeneic transplant, and CAR-T trials – Amadeus, COSI, MERC K, ALL-RIC, AUTO3, AUTO4, AUTO1, AUTO LT FU Sub-Investigator for Myeloid malignancies trials – AML18, AML19, PACE.

  • In addition to academic and professional excellence, Dr. Rajendra is proficient in Hindi, English, Marathi and Gujarati. He has treated patients from across the country and believes in having interactive communication with the patients. This helps him create a personalised treatment plan and enhances the patient experience. 

  • Field of Expertise

  • Haematology
  • Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati
  • Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.
  • World Thalassemia Day: Dr. Rajendra Pol, Haematologist at Manipal Hospital, Baner, Pune. Click Here
  • World Sickle Cell Day: All you need to know about Sickle cell - Dr Rajendra Pol. Click Here

    Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati
  • Overview

  • Dr. Rajendra Pol is a distinguished haematologist in Baner, Pune, who did an MBBS from Pune University in the year 1999, he pursued an MD in medicine from Pune University in the year 2002. Dr. Rajendra then relocated to the UK and further pursued MRCP Medicine in the year 2006 from the Royal College of Physicians U.K. He then achieved FRCPathology-Hematology from the Royal College of Physicians UK in the year 2014 a fellowship in Bone marrow Transplant in the years 2015-2016 satisfying the BSBMT UK curriculum. Dr. Pol over 20 years has done over 5000 autologous transplants, 1000 allogeneic transplants (donors from siblings, unrelated matched, umbilical cord, and haploidentical sources), and 55 CAR-T therapies. Dr. Rajendra has more than 12 years of experience in the field and is one of the highly trusted haematologists in Pune.

  • He also achieved expertise in CAR-T therapy in Manchester for a year. He is an expert in interpreting Bone marrow Biopsies and correlating with MRD and molecular studies pre and post-allogeneic stem cell transplantation. His expertise is in Bone marrow / Haematopoetic stem cell transplantation, He does chemotherapies and has been known to treat a variety of bone marrow cancers like Leukemia, Lymphoma, Myeloma, Bone marrow failures, etc. He has been a Principal Investigator for many UK and International trials like the MoTD trial for allogeneic stem cell transplant recipients, Sub-Investigator for allogeneic transplant, and CAR-T trials – Amadeus, COSI, MERC K, ALL-RIC, AUTO3, AUTO4, AUTO1, AUTO LT FU Sub-Investigator for Myeloid malignancies trials – AML18, AML19, PACE.

  • In addition to academic and professional excellence, Dr. Rajendra is proficient in Hindi, English, Marathi and Gujarati. He has treated patients from across the country and believes in having interactive communication with the patients. This helps him create a personalised treatment plan and enhances the patient experience. 

  • Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.
  • Field of Expertise

  • Haematology
  • Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.
  • World Thalassemia Day: Dr. Rajendra Pol, Haematologist at Manipal Hospital, Baner, Pune. Click Here
  • World Sickle Cell Day: All you need to know about Sickle cell - Dr Rajendra Pol. Click Here

    Field of Expertise

  • Haematology
  • Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.
  • Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati
  • Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.
  • World Thalassemia Day: Dr. Rajendra Pol, Haematologist at Manipal Hospital, Baner, Pune. Click Here
  • World Sickle Cell Day: All you need to know about Sickle cell - Dr Rajendra Pol. Click Here
  • Overview

  • Dr. Rajendra Pol is a distinguished haematologist in Baner, Pune, who did an MBBS from Pune University in the year 1999, he pursued an MD in medicine from Pune University in the year 2002. Dr. Rajendra then relocated to the UK and further pursued MRCP Medicine in the year 2006 from the Royal College of Physicians U.K. He then achieved FRCPathology-Hematology from the Royal College of Physicians UK in the year 2014 a fellowship in Bone marrow Transplant in the years 2015-2016 satisfying the BSBMT UK curriculum. Dr. Pol over 20 years has done over 5000 autologous transplants, 1000 allogeneic transplants (donors from siblings, unrelated matched, umbilical cord, and haploidentical sources), and 55 CAR-T therapies. Dr. Rajendra has more than 12 years of experience in the field and is one of the highly trusted haematologists in Pune.

  • He also achieved expertise in CAR-T therapy in Manchester for a year. He is an expert in interpreting Bone marrow Biopsies and correlating with MRD and molecular studies pre and post-allogeneic stem cell transplantation. His expertise is in Bone marrow / Haematopoetic stem cell transplantation, He does chemotherapies and has been known to treat a variety of bone marrow cancers like Leukemia, Lymphoma, Myeloma, Bone marrow failures, etc. He has been a Principal Investigator for many UK and International trials like the MoTD trial for allogeneic stem cell transplant recipients, Sub-Investigator for allogeneic transplant, and CAR-T trials – Amadeus, COSI, MERC K, ALL-RIC, AUTO3, AUTO4, AUTO1, AUTO LT FU Sub-Investigator for Myeloid malignancies trials – AML18, AML19, PACE.

  • In addition to academic and professional excellence, Dr. Rajendra is proficient in Hindi, English, Marathi and Gujarati. He has treated patients from across the country and believes in having interactive communication with the patients. This helps him create a personalised treatment plan and enhances the patient experience. 

    Talks & Publications

  • Bone marrow fibrosis is not a predictor of overall survival in patients with multiple myeloma. R Pol, S Paneesha, N Chachlani, H Freeman, P Roberts, G Pratt, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Dexamethasone, Ifosfamide, Carboplatin and Etoposide (DICarE) with/out Rituximab is an effective regimen for elderly patients with high-grade lymphoma and poor cardiac function. S Paneesha, C Connor, R Pol, N Evans, N Chachlani, P Rose and A Borg. British Journal of Haematology 2006, 108, 133, (Suppl. 1), 1-121 (Abstract).
  • Bone Marrow Fibrosis is a Negative Predictor for Osteolytic Lesions in Patients with Myeloma. S Paneesha, Raj Pol, N Chachlani, Guy Pratt, Peter Rose and Anton Borg. ‘American Society of Haematology’ Dec 2006. ‘British Journal of Haematology 2007’.
  • Image: ‘All that glitters is not gold’ (Thrombocytosis as a manifestation of renal cell carcinoma). S Paneesha, R Pol. N Chachlani, M Hughes, K Chen, P Rose and A Borg. Bloodmed 2006.
  • http://www.bloodmed.com/education/case1.asp?id=2065. The use of a faecal management device in gastrointestinal graft-versus-host disease.
  • S. Liebersbach, A. Wood, N. Davis, R. Pol, R. Mazumdar, G. Cook, M. Gilleece (Leeds, UK), 36th Annual Meeting of the European Group for Blood and Marrow Transplantation, Vienna, Austria, March 2010.
  • Image - Daunorubicin-induced Hyperpigmentation, published in British Journal of Haematology in Aug 2010. Raj Pol, Andrew Wright, Anita Hill.
  • Image – A man with anaemia and a change in personality, Blood, March 2014. Raj Pol, Martin Howard.
  • A Single centre experience in severe Veno-Occlusive Disease and Early Treatment with Defibrotide. Raj R. Pol, Nigel Russell, Emma Das-Gupta, Lynne Watson, Lisa Rachael, Jenny Byrne. Bone Marrow Transplantation advance online publication, 25 April 2016; doi:10.1038/bmt.2016.99. Also EBMT oral presentation in 2016.
  • Effective Treatment of Steroid and Therapy-R.
  • World Thalassemia Day: Dr. Rajendra Pol, Haematologist at Manipal Hospital, Baner, Pune. Click Here
  • World Sickle Cell Day: All you need to know about Sickle cell - Dr Rajendra Pol. Click Here
  • Overview

  • Dr. Rajendra Pol is a distinguished haematologist in Baner, Pune, who did an MBBS from Pune University in the year 1999, he pursued an MD in medicine from Pune University in the year 2002. Dr. Rajendra then relocated to the UK and further pursued MRCP Medicine in the year 2006 from the Royal College of Physicians U.K. He then achieved FRCPathology-Hematology from the Royal College of Physicians UK in the year 2014 a fellowship in Bone marrow Transplant in the years 2015-2016 satisfying the BSBMT UK curriculum. Dr. Pol over 20 years has done over 5000 autologous transplants, 1000 allogeneic transplants (donors from siblings, unrelated matched, umbilical cord, and haploidentical sources), and 55 CAR-T therapies. Dr. Rajendra has more than 12 years of experience in the field and is one of the highly trusted haematologists in Pune.

  • He also achieved expertise in CAR-T therapy in Manchester for a year. He is an expert in interpreting Bone marrow Biopsies and correlating with MRD and molecular studies pre and post-allogeneic stem cell transplantation. His expertise is in Bone marrow / Haematopoetic stem cell transplantation, He does chemotherapies and has been known to treat a variety of bone marrow cancers like Leukemia, Lymphoma, Myeloma, Bone marrow failures, etc. He has been a Principal Investigator for many UK and International trials like the MoTD trial for allogeneic stem cell transplant recipients, Sub-Investigator for allogeneic transplant, and CAR-T trials – Amadeus, COSI, MERC K, ALL-RIC, AUTO3, AUTO4, AUTO1, AUTO LT FU Sub-Investigator for Myeloid malignancies trials – AML18, AML19, PACE.

  • In addition to academic and professional excellence, Dr. Rajendra is proficient in Hindi, English, Marathi and Gujarati. He has treated patients from across the country and believes in having interactive communication with the patients. This helps him create a personalised treatment plan and enhances the patient experience. 

  • Fellowship & Membership

  • British Society of Heamatology UK.
  • Member of Royal College of Pathologists UK.
  • Field of Expertise

  • Haematology
  • Languages Spoken

  • English
  • Hindi
  • Marathi
  • Gujrati

Doctor Videos

Blogs

Google Reviews

9 Google reviews

FAQ's

Patients often seek Dr. Rajendra Pol’s expertise as the Consultant - Heamatology at Manipal Hospitals Baner - Pune. Dr. Rajendra Pol is a famous Heamatologist in Baner Pune, working with Manipal Hospitals. He has a vast knowledge of Heamatology. Book an appointment with him for a consultation.